glp-1 pipeline news What to know about the new era of drugs GLP-1 Receptor Agonists as Treatments

MOTS-c may not fit research involving: Models where pure, rapid adipose tissue reduction is the only metric Research requiring oral bioavailability (MOTS-c is typically injected due to peptide degradation in the stomach) 5-Amino-1MQ may not fit research involving: Models focused on insulin sensitivity (it does not directly impact insulin receptors) Longevity research focused on mitochondrial biogenesis (it acts on NAD+ in fat, not mitochondrial genesis) Studies looking for exercise-mimetic effects on skeletal muscle Common Mistakes Mistake: Classifying 5-Amino-1MQ as a peptide

A.ReynafarjeC.RamosJ.et al (1968)

Yes, youve already been on a GLP-1 medication, but tirzepatide works on two receptors instead of one, so your body needs time to get used to it

For wound healing, 2 to 3 mg daily is common

When you hear xerostomia, you may be thinking, Zero what? Its actually a scientific term for having a dry mouth due to insufficient saliva production

It may be a viable option for treatment-resistant depression, PTSD, and anxiety , particularly in cases linked to inflammation or chronic pain conditions